Colorectal cancer (CRC) is the third most prevalent malignancy, and has a high mortality rate.[1] CRC typically results from chromosomal instability with the development of mutations in specific oncogenes/tumor suppressor genes such as TP53, KRAS, and APC. Here, KRAS is linked to colorectal carcinoma.